Can-Fite BioPharma Ltd. (CANF)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
After hours:
| Previous close | 2.0300 |
| Open | 2.1000 |
| Bid | 2.0000 x 1400 |
| Ask | 2.1300 x 3000 |
| Day's range | 2.0200 - 2.1500 |
| 52-week range | 1.8100 - 3.3300 |
| Volume | |
| Avg. volume | 17,735 |
| Market cap | 10.43M |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Can-Fite (CANF) Up on Liver Cancer Study Update of Namodenoson
Can-Fite (CANF) stock up 7% as the liver cancer patient achieves a complete response and overall survival of 6.9 years upon continued treatment with namodenoson in a phase II study.
- Zacks
Can-Fite Biopharma Ltd (CANF) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Can-Fite Biopharma Ltd (CANF), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
- Zacks
Best Momentum Stocks to Buy for October 27th
VRT, PGR and CANF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 27, 2023.
© 2024 Yahoo. All rights reserved.